A food court in Dhaka on Wednesday ordered Ibn Sina Pharmaceutical to recall its fruit syrup brand Sinarose from market because of false, confusing and misleading information on its label.
The court of special metropolitan magistrate AFM Maruf Chowdhury also cautioned the company against using false and confusing information in the promotional materials of the fruit syrup brand.
It also asked the company to withdraw without any delay all advertisements of the product containing such information.
The order came in response to a time prayer made by Ibn Sina chairman Shah Abdul Hannan, who was unable to appear before the court due to ill health and sought for time through his lawyers.
The defence lawyers told the court that their client already ordered a recall of its Sinarose product from market.
They told the court that their client would carry out the court order without any delay.
The court fixed October 25 to hear the case again.
On Monday, a day after a warrant was issued by the court to arrest the Ibn Sina chairman, Hannan came in an ambulance to seek bail from the court.
Several doctors accompanied the 80-year-old man, said Kamrul Hasan, the safe food inspector who accused Hannan of cheating consumers through deceptive advertisements on September 6.
In the case statement Kamrul accused the company of using ingredients that were not permitted to be used in the production of fruit syrup.
Sinarose sharbat and fruit syrup, Kamrul mentioned, claimed on its label that it was made of floral extracts, an ingredient the application of which was not permitted in the production of any fruit syrup.
He said that the syrup label also carried a statement that it was the world’s number 1 halal drink.
‘It even claims that it is very effective in preventing heat strokes,’ said Kamrul.
The court on Wednesday said Ibn Sina that such statements must be removed from all promotional materials of the syrup.
Ibn Sina Pharmaceutical is facing another case on similar charges involving its other syrup brand Biorose sharbat and fruit syrup.
The accused in the case, Ibn Sina Pharmaceutical managing director Mizanur Rahman, already pleaded guilty to the court.
The court is expected to deliver a verdict in the case on September 30.
Want stories like this in your inbox?
Sign up to exclusive daily email
More Stories from Country